Skip to content
10-Q

Quarterly Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000808

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Dec 16, 2022 78.36M sh
Stockholders Equity Q1 2018 · Dec 31, 2018 −$223.95K
Stockholders Equity Q1 2018 · Sep 30, 2018 −$221.09K
Stockholders Equity Q1 2018 · Dec 31, 2017 −$200.31K
Stockholders Equity Q1 2018 · Sep 30, 2017 −$192.69K
Current Liabilities Q1 2018 · Dec 31, 2018 $224.72K
Current Liabilities Q1 2018 · Sep 30, 2018 $223.36K
Total Liabilities Q1 2018 · Dec 31, 2018 $224.72K
Total Liabilities Q1 2018 · Sep 30, 2018 $223.36K
Current Assets Q1 2018 · Dec 31, 2018 $764
Current Assets Q1 2018 · Sep 30, 2018 $2.27K
Total Assets Q1 2018 · Dec 31, 2018 $764
Total Assets Q1 2018 · Sep 30, 2018 $2.27K
Net Income Q1 2018 · Dec 31, 2018 −$2.86K
Net Income Q1 2018 · Dec 31, 2017 −$7.63K
Operating Cash Flow Q1 2018 · Dec 31, 2017 −$155
Operating Income Q1 2018 · Dec 31, 2017 −$7.03K